15271 reports a skin-substitute application service for qualifying sites and areas; A2027 identifies the MatriDerm product by square centimeter.
On this page
CMS RVU26D · Effective 2026-10-01
A2027 Matriderm Medicare reimbursement rates in Iowa
Report A2027 for each square centimeter of MatriDerm dermal matrix supplied with a qualifying primary procedure for wound or burn reconstruction. Compare A2027 office and facility rates across CMS payment localities in Iowa.
Amounts below use the non-QP conversion factor for participating physicians. These are base physician payments before claim-level adjustments, not patient costs or total hospital charges.
What does Medicare pay for A2027 in Iowa?
Iowa has 1 payment locality in this comparison. Use the service location to choose the applicable amount. These are the supported base rates for the payment area shown below, using the same CMS release.
Office / nonfacility
$116.44
1 of 1 localities have a supported rate.
Payment area: Iowa
One mapped payment locality.
Facility setting
No supported rate
These are locality ranges, not averages or address-specific quotes. A facility-setting amount covers the physician service; it does not include a hospital’s separate bill. Choose a locality below to inspect its calculation, compare other payment areas, or price a percentage of Medicare.
Wound care supplies
About A2027: Matriderm dermal matrix supply
Report A2027 for each square centimeter of MatriDerm dermal matrix supplied with a qualifying primary procedure for wound or burn reconstruction.
A2027 identifies MatriDerm, a collagen-and-elastin dermal matrix used in wound and burn reconstruction, including as a scaffold in procedures that may also use a skin graft. The product is measured by surface area. It may be used in surgical settings by clinicians treating complex wounds or burns; the associated application or reconstruction procedure is reported separately as the primary service.
Report A2027 only with a primary procedure, and count units according to the documented square centimeters of MatriDerm supplied. The record should identify the product, treatment site, amount used, and the primary procedure performed. CMS treats A2027 as an add-on paid within the primary procedure’s global period. It is technical-component-only; a separate code represents interpretation, when applicable.
CMS billing rules for A2027
- Global period
- Add-on code: billed only together with a primary procedure and paid within that procedure's global period.
- Professional and technical components
- Technical-component-only code: a separate code covers interpretation.
Where the value comes from
- Work RVU0.00 · 0%
- Practice expense (office) RVU3.81 · 100%
- Malpractice RVU0.00 · 0%
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
A2027 compared with similar codes
Office rates for Iowa, from the same CMS release.
15272 reports additional qualifying application area under the skin-substitute procedure family. It does not represent the MatriDerm supply itself.
A2021 identifies Neomatrix, a different named product. Use the product-specific supply code rather than choosing by the shared per-square-centimeter unit.
Compare A2027 by payment locality
Find the payment area for your service address, then open its rate page for calculation inputs, release history and the percentage-of-Medicare tool. A city may cross payment-area boundaries; the ZIP lookup above helps resolve the location.
1 of 1 payment localities
Iowa →
Office / nonfacility
$116.44
Facility
Unavailable
Need rates for a whole code list?
Fee-sheet and API access are in early access. Tell us which codes and locations your team needs.
How this local rate is calculated
Each RVU component is multiplied by its own geographic practice cost index (GPCI). The three adjusted components are added, then multiplied by the conversion factor. These are the inputs used for A2027 in Iowa.
PPRRVU2026_Oct_nonQPP.csv
13,248
- Code
- A2027
- Physician work
- 0.00
- Practice expense
- 3.81
- Malpractice
- 0.00
GPCI2026.csv
53
- Locality
- Iowa
- Physician work
- 1.000
- Practice expense
- 0.915
- Malpractice
- 0.397
| Component | RVU | Locality factor | Adjusted |
|---|---|---|---|
| Physician work | 0.00 | × 1.000 | 0.0000 |
| Practice expense | 3.81 | × 0.915 | 3.4862 |
| Malpractice | 0.00 | × 0.397 | 0.0000 |
| Total RVUs | 3.4862 | ||
| Conversion factor | × 33.4009 | ||
Office / nonfacility rate, Iowa$116.44
Explore RVUs, geographic factors and the full formula
Office / nonfacility
| Component | RVU | Local GPCI |
|---|---|---|
| Work | 0 | 1 |
| Practice expense | 3.81 | 0.915 |
| Malpractice | 0 | 0.397 |
(0 × 1 + 3.81 × 0.915 + 0 × 0.397) × $33.4009 = $116.44
The office and facility calculations use their respective practice-expense RVUs. The facility amount here is the physician fee, not a separate hospital or facility bill.
A2027 billing questions
Is A2027 reported by wound area or product area?
The code is measured per square centimeter of MatriDerm. Document the amount of product used and support the units billed.
Can A2027 be billed by itself?
No. CMS identifies it as an add-on code that must be billed with a primary procedure.
Which application code should accompany A2027?
Select the primary procedure based on the service performed, treatment site, and applicable procedure criteria. A2027 does not replace the application or reconstruction procedure.
How does the global-period rule affect A2027?
Payment for A2027 is included within the global period of the primary procedure with which it is billed.
What does technical-component-only mean for this code?
A2027 represents the technical component; a separate code represents interpretation when applicable.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense, and malpractice RVUs, adjusted by each locality’s geographic indices and the applicable conversion factor. Unavailable or separately priced services are labeled rather than assigned a made-up amount.
Source: RVU26D. Effective 2026-10-01 through the day before 2027-01-01.
